S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

June 30, 2010

Conditions
Tobacco Dependence
Interventions
DRUG

S-Adenosyl-L-Methionine

800 mg dose per day for 8 weeks

DRUG

S-Adenosyl-L-Methionine

1600 mg per day for 8 weeks

OTHER

placebo

4 pills (2 in the AM and 2 in the PM) of placebos for 8 weeks

Trial Locations (2)

54601

Franciscan Skemp HealthCare, La Crosse

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pharmavite LLC

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00722124 - S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence | Biotech Hunter | Biotech Hunter